首页> 美国卫生研究院文献>Journal of Thoracic Disease >Endobronchial ultrasound-guided intranodal forceps biopsy (EBUS-IFB)—technical review
【2h】

Endobronchial ultrasound-guided intranodal forceps biopsy (EBUS-IFB)—technical review

机译:支气管内超声引导下的结内镊活检(EBUS-IFB)—技术评论

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Endobronchial ultrasound (EBUS) and transbronchial needle aspiration (TBNA) have changed the landscape of pulmonology. Mediastinal structures beyond the confines of airway walls are visualized in real-time with EBUS, leading to improved accuracy of tissue sampling and diagnostic yield. With the development of various needle sizes ranging from 25-G to 19-G, the sampling of lymph nodes is becoming easier and more commonplace. Yet, certain conditions such as sarcoidosis and lymphoma may still be difficult to diagnose via EBUS-TBNA. Furthermore, in the age of targeted therapy, there are more demands on EBUS-TBNA samples for molecular marker testing and next-generation sequencing. Here, we present a complementary methodology, EBUS-guided intranodal forceps biopsy (EBUS-IFB), for tissue acquisition that may help address these deficiencies. Specifically, we aim to propose indications, contraindications, outline approaches in performing IFB, and provide an overview of the data for this complementary technique.
机译:支气管内超声(EBUS)和经支气管针吸术(TBNA)改变了肺科的面貌。 EBUS实时显示气道壁范围以外的纵隔结构,从而提高了组织采样的准确性和诊断率。随着从25-G到19-G的各种针头尺寸的发展,淋巴结的采样变得越来越容易和普遍。然而,某些病状如结节病和淋巴瘤仍可能难以通过EBUS-TBNA进行诊断。此外,在靶向治疗时代,对EBUS-TBNA样品的分子标记测试和下一代测序的需求越来越高。在这里,我们提出了一种补充方法,即以EBUS引导的结内镊子活检(EBUS-IFB),用于组织获取,这可能有助于解决这些缺陷。具体来说,我们旨在提出进行IFB的适应症,禁忌症,治疗方法概述,并概述这种补充技术的数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号